The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications
Open accessAbstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are used chronically to reduce pain and inflammation in patients with arthritic conditions, and also acutely as analgesics by many patients. Both therapeutic and adverse effects of NSAIDs are due to inhibition of cyclooxygenase (COX) enzyme. NSAIDs are classified as non-selective and COX-2-selective inhibitors (COXIBS) based on their extent of selectivity for COX inhibition. However, regardless of their COX selectivity, reports are still appearing on the GI side effect of NSAIDs particularly on the lower gastrointestinal (GI) tract and the harmful role of their controlled release formulations. In addition, previously unpublished data stored in the sponsor’s files, question the GI sparing properties of rofecoxib, a COXIB that has been withdrawn due to cardiovascular (CV) side effects. Presently, the major side effects of NSAIDs are the GI complications, renal disturbances and CV events. There is a tendency to believe that all NSAIDs are associated with renal and CV side effects, a belief that is not supported by solid evidence. Indeed, lower but still therapeutics doses of some NSAIDs may be cardioprotective. In this review, we briefly discuss the GI toxicity of the NSAIDs and assess their renal and CV adverse effects in more detail. This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Safar, P., & Grenvik, A. (1971) · Chest · doi:10.1378/chest.59.5.535 · Cited by 1,989
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
Anavekar, N. S., McMurray, J. J. V., Velazquez, E. J., Solomon, S. D., Kober, L., Rouleau, J.-L., White, H. D., Nordlander, R., Maggioni, A., Dickstein, K., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041365 · Cited by 1,917
Risk of Cardiovascular Events Associated with Selective COX-2 Inhibitors
Mukherjee, D. (2001) · JAMA · doi:10.1001/jama.286.8.954 · Cited by 1,741
Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519
Meade, E. A., Smith, W. L., & DeWitt, D. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53294-4 · Cited by 1,256
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Trelle, S., Reichenbach, S., Wandel, S., Hildebrand, P., Tschannen, B., Villiger, P. M., Egger, M., & Juni, P. (2011) · BMJ · doi:10.1136/bmj.c7086 · Cited by 1,166
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
Bertagnolli, M. M., Eagle, C. J., Zauber, A. G., Redston, M., Solomon, S. D., Kim, K., Tang, J., Rosenstein, R. B., Wittes, J., Corle, D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061355 · Cited by 1,048
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
Cardiovascular death in rheumatoid arthritis: A population‐based study
Maradit‐Kremers, H., Nicola, P. J., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20878 · Cited by 934
McEvoy, G. K. (1994) · Oncology Issues · doi:10.1080/10463356.1994.11904493 · Cited by 888
Rao, P., & Knaus, E. E. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3t886 · Cited by 773
Sostres, C., Gargallo, C. J., Arroyo, M. T., & Lanas, A. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2009.11.005 · Cited by 685
Catella-Lawson, F., McAdam, B., Morrison, B. W., Kapoor, S., Kujubu, D., Antes, L., Lasseter, K. C., Quan, H., Gertz, B. J., & Fitzgerald, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 597
Hippisley-Cox, J., & Coupland, C. (2005) · BMJ · doi:10.1136/bmj.330.7504.1366 · Cited by 561
Prostanoids in health and disease
Smyth, E. M., Grosser, T., Wang, M., Yu, Y., & FitzGerald, G. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800094-jlr200 · Cited by 543
Solomon, D. H., Schneeweiss, S., Glynn, R. J., Kiyota, Y., Levin, R., Mogun, H., & Avorn, J. (2004) · Circulation · doi:10.1161/01.cir.0000127578.21885.3e · Cited by 509
Analgesic-Antipyretic and Antiinflammatory Agents and Drugs Employed in the Treatment of Gout
Insel, P. (1996) · Medical Entomology and Zoology · Cited by 458
Gislason, G. H., Jacobsen, S., Rasmussen, J. N., Rasmussen, S., Buch, P., Friberg, J., Schramm, T. K., Abildstrom, S. Z., Køber, L., Madsen, M., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.616219 · Cited by 447
McGettigan, P., & Henry, D. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001388 · Cited by 414
Conaghan, P. G. (2012) · Rheumatology International · doi:10.1007/s00296-011-2263-6 · Cited by 407
Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions
Ritter, J. K. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00198-8 · Cited by 386
Nonsteroidal Anti-Inflammatory Drugs: Adverse Effects and Their Prevention
Vonkeman, H. E., & van de Laar, M. A. F. J. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.08.001 · Cited by 365
An overview of drug-induced acute kidney injury
Pannu, N., & Nadim, M. K. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318168e375 · Cited by 352
Schjerning Olsen, A.-M., Fosbøl, E. L., Lindhardsen, J., Folke, F., Charlot, M., Selmer, C., Lamberts, M., Bjerring Olesen, J., Køber, L., Hansen, P. R., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.004671 · Cited by 335
Whelton, A., Fort, J. G., Puma, J. A., Normandin, D., Bello, A. E., & Verburg, K. M. (2001) · American Journal of Therapeutics · doi:10.1097/00045391-200103000-00003 · Cited by 334
Zhang, J., Ding, E. L., & Song, Y. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60015 · Cited by 332
García Rodríguez, L. A., Tacconelli, S., & Patrignani, P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.041 · Cited by 305
Gislason, G. H., Rasmussen, J. N., Abildstrom, S. Z., Schramm, T. K., Hansen, M. L., Fosbøl, E. L., Sørensen, R., Folke, F., Buch, P., Gadsbøll, N., et al. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.525 · Cited by 295
Krumholz, H. M. (2008) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.814509 · Cited by 289
Johnsen, S. P. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.9.978 · Cited by 288
Nonsteroidal Anti‐Inflammatory Drugs: Effects on Kidney Function
Whelton, A., & Hamilton, C. W. (1991) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1991.tb03743.x · Cited by 282
Ten year mortality and causes of death in patients with rheumatoid arthritis.
Mutru, O., Laakso, M., Isomäki, H., & Koota, K. (1985) · BMJ · doi:10.1136/bmj.290.6484.1797 · Cited by 264
Renal adverse effects of nonsteroidal anti-inflammatory drugs
Harirforoosh, S., & Jamali, F. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903311023 · Cited by 261
Self-citationNonsteroidal anti-inflammatory drugs: Effects on kidney function
Whelton, A., & Watson, A. J. (1998) · Clinical Nephrotoxins · doi:10.1007/978-94-015-9088-4_14 · Cited by 261
Zidar, N., Odar, K., Glavac, D., Jerse, M., Zupanc, T., & Stajer, D. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00430.x · Cited by 255
Ombardier, C. L. B., Aine, L. O. L., Eicin, A. L. R., Hapiro, D. E. S., Urgos, R. U. B., Avis, B. A. D., Ay, R., Arcos, M. J., Erraz, B. O. F., Awkey, C. H. J. H., et al. (2010) · Cited by 253
Lévesque, L. E., Brophy, J. M., & Zhang, B. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00113 · Cited by 249
Brater, D. C. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00369-1 · Cited by 247
Drug induced hypertension--An unappreciated cause of secondary hypertension.
Grossman, A., Messerli, F., & Grossman, E. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.027 · Cited by 241
Claria, J. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454054 · Cited by 238
McCormack, P. L. (2011) · Drugs · doi:10.2165/11208240-000000000-00000 · Cited by 224
Helin-Salmivaara, A. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl053 · Cited by 211
The renal effects of nonsteroidal anti-inflammatory drugs: Summary and recommendations
Bennett, W. M., Henrich, W. L., & Stoff, J. S. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90570-3 · Cited by 194
Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
Bertagnolli, M. M., Eagle, C. J., Zauber, A. G., Redston, M., Breazna, A., Kim, K., Tang, J., Rosenstein, R. B., Umar, A., Bagheri, D., et al. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0206 · Cited by 193
Fosbøl, E., Gislason, G., Jacobsen, S., Folke, F., Hansen, M., Schramm, T., Sørensen, R., Rasmussen, J., Andersen, S., Abildstrom, S., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.204 · Cited by 192
LAINE, L., SMITH, R., MIN, K., CHEN, C., & DUBOIS, R. W. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03043.x · Cited by 189
Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension
Grossman, E., & Messerli, F. H. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.05.024 · Cited by 183
Renal Safety and Tolerability of Celecoxib, a Novel Cyclooxygenase-2 Inhibitor
Whelton, A., Maurath, C. J., Verburg, K. M., & Geis, G. S. (2000) · American Journal of Therapeutics · doi:10.1097/00045391-200007030-00004 · Cited by 167
Fosbøl, E. L., Folke, F., Jacobsen, S., Rasmussen, J. N., Sørensen, R., Schramm, T. K., Andersen, S. S., Rasmussen, S., Poulsen, H. E., Køber, L., et al. (2010) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.861104 · Cited by 167
Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status
Nishihara, R., Lochhead, P., Kuchiba, A., Jung, S., Yamauchi, M., Liao, X., Imamura, Y., Qian, Z. R., Morikawa, T., Wang, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6599 · Cited by 166
Schwartz, J. I., Vandormael, K., Malice, M. P., Kalyani, R. N., Lasseter, K. C., Holmes, G. B., Gertz, B. J., Gottesdiener, K. M., Laurenzi, M., Redfern, K. ‐., et al. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.126182 · Cited by 161
Curfman, G. D., Morrissey, S., & Drazen, J. M. (2005) · New England Journal of Medicine · doi:10.1056/nejme058314 · Cited by 158
Frequency of Analgesic Use and Risk of Hypertension Among Men
Forman, J. P., Rimm, E. B., & Curhan, G. C. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.4.394 · Cited by 156
Schmidt, M., Christiansen, C. F., Mehnert, F., Rothman, K. J., & Sørensen, H. T. (2011) · BMJ · doi:10.1136/bmj.d3450 · Cited by 153
Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review
Nderitu, P., Doos, L., Jones, P. W., Davies, S. J., & Kadam, U. T. (2013) · Family Practice · doi:10.1093/fampra/cms086 · Cited by 150
Varas‐Lorenzo, C., Riera‐Guàrdia, N., Calingaert, B., Castellsagué, J., Salvo, F., Nicotra, F., Sturkenboom, M., & Perez‐Gutthann, S. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3437 · Cited by 147
Nonsteroidal Anti-Inflammatory Drugs and Heart Failure
Bleumink, G. S., Feenstra, J., Sturkenboom, M., & Stricker, B. H. C. (2003) · Drugs · doi:10.2165/00003495-200363060-00001 · Cited by 147
Current approaches to prevent NSAID‐induced gastropathy – COX selectivity and beyond
Becker, J. C., Domschke, W., & Pohle, T. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02198.x · Cited by 134
Mayo, P., Skeith, K. J., Russell, A. S., & Jamali, F. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00314.x · Cited by 133
Self-citationLiu, J., Li, N., Yang, J., Li, N., Qiu, H., Ai, D., Chiamvimonvat, N., Zhu, Y., & Hammock, B. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011278107 · Cited by 133
Chan, C. C., Reid, C. M., Aw, T., Liew, D., Haas, S. J., & Krum, H. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283310dc9 · Cited by 133
Lindhardsen, J., Gislason, G., Jacobsen, S., Ahlehoff, O., Olsen, A. S., Madsen, O. R., Torp-Pedersen, C. T., & Hansen, P. R. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203137 · Cited by 133
Laine, L., Curtis, S., Langman, M. J. S., Jensen, D. M., Cryer, B., Kaur, A., & Cannon, C. P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.067 · Cited by 133
Cyclooxygenase 2 and the kidney
Breyer, M. D., & Harris, R. C. (2001) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200101000-00014 · Cited by 131
Fujimori, S., Seo, T., Gudis, K., Ehara, A., Kobayashi, T., Mitsui, K., Yonezawa, M., Tanaka, S., Tatsuguchi, A., & Sakamoto, C. (2009) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2008.08.017 · Cited by 127
Nonsteroidal anti‐inflammatory drug use and the risk of cognitive impairment and Alzheimer's disease
Côté, S., Carmichael, P., Verreault, R., Lindsay, J., Lefèbvre, J., & Laurin, D. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.03.012 · Cited by 126
Becker, M. C., Wang, T. H., Wisniewski, L., Wolski, K., Libby, P., Lüscher, T. F., BORER, J. S., Mascette, A. M., Husni, M. E., Solomon, D. H., et al. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.12.014 · Cited by 124
Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity
Knights, K., Mangoni, A. A., & Miners, J. O. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.120 · Cited by 118
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology
Arvanitakis, Z., Grodstein, F., Bienias, J. L., Schneider, J. A., Wilson, R. S., Kelly, J. F., Evans, D. A., & Bennett, D. A. (2008) · Neurology · doi:10.1212/01.wnl.0000313813.48505.86 · Cited by 116
Shibata, M., Kodani, I., Osaki, M., Araki, K., Adachi, H., Ryoke, K., & Ito, H. (2005) · Oral Oncology · doi:10.1016/j.oraloncology.2004.09.009 · Cited by 116
The fight against rheumatism: from willow bark to COX-1 sparing drugs.
Vane, J. R. (2000) · PubMed · Cited by 115
Lanas, Á., Tornero, J., & Zamorano, J. L. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.123166 · Cited by 115
Laine, L., Kivitz, A., Bello, A. E., Grahn, A. Y., Schiff, M. H., & Taha, A. S. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.443 · Cited by 101
Protective Effects of Angiotensin II Interruption: Evidence for Antiinflammatory Actions
Dagenais, N. J., & Jamali, F. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.9.1213 · Cited by 94
Self-citationGoodson, N. J., Brookhart, A. M., Symmons, D. P. M., Silman, A. J., & Solomon, D. H. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.076760 · Cited by 94
Ejaz, P., Bhojani, K. S., & Joshi, V. (2004) · PubMed · Cited by 93
Aljadhey, H. S., Tu, W., Hansen, R. A., Blalock, S. J., Brater, D. C., & Murray, M. D. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-93 · Cited by 93
Cyclooxygenase-3: axiom, dogma, anomaly, enigma or splice error?--Not as easy as 1, 2, 3.
Davies, N. M., Good, R. L., Roupe, K., & Yáñez, J. A. (2004) · PubMed · Cited by 93
Stroke risk and NSAIDs: a systematic review of observational studies
Varas‐Lorenzo, C., Riera‐Guàrdia, N., Calingaert, B., Castellsagué, J., Pariente, A., Scotti, L., Sturkenboom, M., & Perez‐Gutthann, S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2227 · Cited by 92
Klinge, S. A., & Sawyer, G. A. (2013) · The Physician and Sportsmedicine · doi:10.3810/psm.2013.05.2016 · Cited by 90
Renal complications associated with use of nonsteroidal anti-inflammatory agents.
Palmer, B. F. (1995) · PubMed · Cited by 89
Mason, R. P., Walter, M. F., McNulty, H. P., Lockwood, S. F., Byun, J., Day, C. A., & Jacob, R. F. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200605001-00003 · Cited by 86
The Effects of Nonsteroidal Anti-Inflammatory Drugs on Blood Pressure in Hypertensive Patients
Snowden, S., & Nelson, R. J. (2011) · Cardiology in Review · doi:10.1097/crd.0b013e31821ddcf4 · Cited by 84
Cyclooxygenase Selectivity of Nonsteroidal Anti-inflammatory Drugs and Risk of Stroke
Haag, M. D. M. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.11.1219 · Cited by 83
Jarupongprapa, S., Ussavasodhi, P., & Katchamart, W. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0717-6 · Cited by 83
Pooled Analysis of Rofecoxib Placebo-Controlled Clinical Trial Data
Ross, J. S. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.394 · Cited by 81
Acute nephrotoxicity of NSAID from the foetus to the adult.
Musu, M., Finco, G., Antonucci, R., Polati, E., Sanna, D., Evangelista, M., Ribuffo, D., Schweiger, V., & Fanos, V. (2011) · PubMed · Cited by 79
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction
Anavekar, N., McMurray, J. J. V., & Velazquez, E. J. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.11.009 · Cited by 79
Fernández‐Llama, P., ECELBARGER, C. A., Ware, J. A., Andrews, P. M., Lee, A. J., Turner, R. J., Nielsen, S., & Knepper, M. A. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.2.f219 · Cited by 76
Long-term Use of Anti-inflammatory Drugs and Risk of Atrial Fibrillation
Caterina, R. D., Ruigómez, A., & Rodríguez, L. A. G. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.305 · Cited by 75
Combe, B. G., Swergold, G. D., McLay, J., McCarthy, T., Zerbini, C. A. F., Emery, P., Connors, L., Kaur, A., Curtis, S., Laine, L., et al. (2009) · Rheumatology · doi:10.1093/rheumatology/kep005 · Cited by 72
Curtis, J. R., Lanas, Á., John, A. K., Johnson, D. A., & Schulman, K. L. (2012) · Arthritis Care & Research · doi:10.1002/acr.21764 · Cited by 71
Knights, K. M., Winner, L. K., Elliot, D. J., Bowalgaha, K., & Miners, J. O. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03469.x · Cited by 70
Is There a Role for PGE2 in Urinary Concentration?
Olesen, E. T. B., & Fenton, R. A. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012020217 · Cited by 70
The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction
Brophy, J. M., Lévesque, L. E., & Zhang, B. (2006) · Heart · doi:10.1136/hrt.2006.089367 · Cited by 69
Roumie, C. L., Choma, N. N., Kaltenbach, L. A., Mitchel, E. F., Arbogast, P. G., & Griffin, M. R. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1820 · Cited by 66
The Glucosamine Controversy; A Pharmacokinetic Issue
Aghazadeh‐Habashi, A., & Jamali, F. (2011) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3xg6f · Cited by 63
Self-citationEffect of Nonsteroidal Anti-Inflammatory Drug Use on the Incidence of Erectile Dysfunction
Shiri, R., Koskimäki, J. E., Häkkinen, J., Tammela, T. L. J., Auvinen, A. P., & Hakama, M. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)01000-1 · Cited by 63
Complexities in the pharmacologic management of osteoarthritis pain
McCarberg, B. H., & Tenzer, P. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.785391 · Cited by 62
Mallen, S. R., Essex, M. N., & Zhang, R. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.581274 · Cited by 61
Sustained release and enteric coated NSAIDs: are they really GI safe?
Davies, N. M. (2000) · PubMed · Cited by 59
Myths and facts in the use of anti-inflammatory drugs
Hunt, R. H., Lanas, Á., Stichtenoth, D. O., & Scarpignato, C. (2009) · Annals of Medicine · doi:10.1080/07853890902887295 · Cited by 59
Nonsteroidal anti‐inflammatory drugs
Zell, J. A., Ziogas, A., Bernstein, L., Clarke, C. A., Deapen, D., Largent, J. A., Neuhausen, S. L., Stram, D. O., Ursin, G., & Anton‐Culver, H. (2009) · Cancer · doi:10.1002/cncr.24705 · Cited by 57
Krum, H., Swergold, G. D., Curtis, S., Kaur, A., Wang, H., Smugar, S. S., Weir, M. R., Laine, L., Brater, D. C., & Cannon, C. P. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328325d831 · Cited by 56
Zhou, Y., Crichton, I., Tang, S. Y., Hui, Y., Ricciotti, E., Levin, M. D., Lawson, J. A., Puré, E., & FitzGerald, G. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115313109 · Cited by 54
Stürmer, T., Erb, A., Keller, F., Günther, K., & Brenner, H. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00942-1 · Cited by 50
Horbach, S., Lópes, R. D., Guaragna, J. C. V. D. C., Martini, F., Mehta, R. H., Petracco, J. B., Bodanese, L. C., Filho, A. C., Cirenza, C., & de Paola, Â. A. V. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.07.026 · Cited by 49
Stroke risk and NSAIDs: an Australian population‐based study
Caughey, G. E., Roughead, E. E., Pratt, N. L., Killer, G. T., & Gilbert, A. L. (2011) · The Medical Journal of Australia · doi:10.5694/mja11.10055 · Cited by 49
Mangoni, A. A., Woodman, R. J., Gaganis, V., Gilbert, A. L., & Knights, K. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03627.x · Cited by 48
Wang, X., Tian, H. J., Yang, H. K., Wanyan, P., & Peng, Y. J. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328349de81 · Cited by 47
Pharmacogenetics of nonsteroidal anti-inflammatory drugs
Wyatt, J. E., Pettit, W. L., & Harirforoosh, S. (2012) · The Pharmacogenomics Journal · doi:10.1038/tpj.2012.40 · Cited by 47
Self-citationNonsteroidal Antiinflammatory Drugs, Acetaminophen, and Hypertension
Sudano, I., Flammer, A. J., Roas, S., Enseleit, F., Noll, G., & Ruschitzka, F. T. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0274-7 · Cited by 46
White, W. B., Schnitzer, T. J., Fleming, R., Duquesroix, B., & Beekman, M. J. H. I. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.05.014 · Cited by 46
Fournier, J., Sommet, A., Durrieu, G., Poutrain, J.-C., Lapeyre‐Mestre, M., & Montastruc, J. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12014 · Cited by 46
Davies, N. M., & Jamali, F. (1997) · Human & Experimental Toxicology · doi:10.1177/096032719701600701 · Cited by 45
Self-citationEXTENT OF RENAL EFFECT OF CYCLO‐OXYGENASE‐2‐SELECTIVE INHIBITORS IS PHARMACOKINETIC DEPENDENT
Harirforoosh, S., Aghazadeh‐Habashi, A., & Jamali, F. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04464.x · Cited by 43
Self-citationChao, T., Liu, C., Chen, S., Wang, K.-L., Lin, Y., Chang, S., Lo, L., Hu, Y., Tuan, T., Wu, T.-J., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.058 · Cited by 43
Dual COXIB/TP antagonists: a possible new twist in NSAID pharmacology and cardiovascular risk
Rovati, G. E., Sala, A., Capra, V., Dahlén, S., & Folco, G. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.007 · Cited by 42
Oral Cyclo-Oxygenase 2 Inhibitors versus Other Oral Analgesics for Acute Soft Tissue Injury
Jones, P., & Lamdin, R. (2010) · Clinical Drug Investigation · doi:10.2165/11533350-000000000-00000 · Cited by 41
Wei, L., MacDonald, T. M., Jennings, C. G., et al. (2013) · Kidney International · doi:10.1038/ki.2013.76 · Cited by 40
Brueggemann, L. I., Mani, B. K., Mackie, A. R., Cribbs, L. L., & Byron, K. L. (2010) · PubMed · Cited by 38
Satoh, H., & Takeuchi, K. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803413980 · Cited by 38
Varas‐Lorenzo, C., Castellsagué, J., Stang, M. R., Perez‐Gutthann, S., Aguado, J., & Rodríguez, L. A. G. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1815 · Cited by 38
Liu, S. S., Bae, J. J., Bieltz, M., Ma, Y., & Memtsoudis, S. G. (2012) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0b013e31823354f5 · Cited by 36
Harirforoosh, S., & Jamali, F. (2005) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-129 · Cited by 35
Self-citationLafrance, J., & Miller, D. R. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.02.328 · Cited by 32
The Role of Angiotensin Receptor Blockers in the Management of Chronic Heart Failure
Jamali, A. H., Tang, W. H. W., Khot, U. N., & Fowler, M. B. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.5.667 · Cited by 29
MacDonald, T. M., Mackenzie, I. S., Wei, L., Hawkey, C. J., & Ford, I. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002295 · Cited by 29
Pro- and Anti-Arrhythmic Effects of Anti-Inflammatory Drugs
Granier, M., Massin, F., & Pasquié, J. (2013) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523011312010010 · Cited by 28
Aghazadeh‐Habashi, A., & Jamali, F. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.07.013 · Cited by 26
Self-citationTreatment of osteoarthritis in hypertensive patients
Mackenzie, I. S., & MacDonald, T. M. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903496422 · Cited by 24
Hegazy, R. M., Alashhab, M., & Amin, M. (2011) · Journal of Toxicology · doi:10.1155/2011/862153 · Cited by 23
Rahme, E., Watson, D. J., Kong, S. X., Toubouti, Y. M., & LeLorier, J. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1339 · Cited by 23
Kerr, S. J., Rowett, D. S., Sayer, G. P., Whicker, S. D., Saltman, D. C., & Mant, A. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03702.x · Cited by 22
Genetic Polymorphisms and the Cardiovascular Risk of Non-Steroidal Anti-Inflammatory Drugs
Germaine, C. G. S., Bogaty, P. M., Boyer, L., Hanley, J. A., Engert, J. C., & Brophy, J. M. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.352 · Cited by 22
THIERS, B. H. (2007) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70536-7 · Cited by 21
Risk of hyperkalemia associated with selective COX‐2 inhibitors
Aljadhey, H. S., Tu, W., Hansen, R. A., Blalock, S. J., Brater, D. C., & Murray, M. D. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2011 · Cited by 19
Kardiovaskuläre Komorbidität und ihre Risikofaktoren bei rheumatoider Arthritis
Kleinert, S., & Krueger, K. (2011) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-011-0755-0 · Cited by 16
Non-steroidal anti-inflammatory drugs: clinical issues
Jordan, S. E., & White, J. (2001) · Nursing Standard · doi:10.7748/ns2001.02.15.23.45.c2986 · Cited by 16
Reiss, A. B., Anwar, F., Chan, E. S. L., & Anwar, K. (2009) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31819ec3c7 · Cited by 16
Grimaldi‐Bensouda, L., Rossignol, M., Danchin, N., Steg, P. G., Bessede, G., Ovize, M., Cottin, Y., Autret‐Leca, E., Bénichou, J., Abenhaim, L., et al. (2011) · Heart · doi:10.1136/hrt.2011.222448 · Cited by 15
Warner, J. J., Weideman, R. A., Kelly, K. C., Brilakis, E. S., Banerjee, S., Cunningham, F. E., Harford, W. V., Kazi, S., Little, B. B., & Cryer, B. (2008) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248408323136 · Cited by 15
Mihovilović, K., Ljubanović, D. G., & Knotek, M. (2011) · Clinical Drug Investigation · doi:10.1007/bf03256934 · Cited by 14
Graham, D. Y., Jewell, N. P., & Chan, F. K. L. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182113658 · Cited by 14
Elliott, W. J. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0120-8 · Cited by 12
Life-threatening hyperkalemia after 2 days of ibuprofen
Platts‐Mills, T. F., Richmond, N. L., Hunold, K. M., & Bowling, C. B. (2013) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2012.09.002 · Cited by 12
Jamali, F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.21.2371-b · Cited by 12
Self-citationRay, I. L., Barkun, A. N., Vauzelle-Kervroedan, F., & Bardou, M. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.016 · Cited by 11
Clements, J. D., & Jamali, F. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3d012 · Cited by 9
Self-citationCardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outs
Capone, M. L., Tacconelli, S., Francesco, L. D., Petrelli, M., & Patrignani, P. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.1.29 · Cited by 9
Celecoxib does not alter cardiovascular and renal function during dietary salt loading
Wenner, M. M., Edwards, D. G., Ray, C. A., Rose, W. C., Gardner, T. J., Stillabower, M. E., & Farquhar, W. B. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05546.x · Cited by 7
Review: studies on the cardiovascular effects of selective COX-2 inhibitors show mixed results
Belknap, S. M. (2002) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.7.2.49 · Cited by 4
Mihovilović, K., Ljubanović, D. G., & Knotek, M. (2011) · Clinical Drug Investigation · doi:10.2165/11586340-000000000-00000 · Cited by 3
Cited by
A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly
Wongrakpanich, S., Wongrakpanich, A., Melhado, K., & Rangaswami, J. (2018) · Aging and disease · doi:10.14336/ad.2017.0306 · Cited by 917
Plants as Sources of Anti-Inflammatory Agents
Nunes, C. D. R., Barreto Arantes, M., Menezes de Faria Pereira, S., Leandro da Cruz, L., de Souza Passos, M., Pereira de Moraes, L., Vieira, I. J. C., & Barros de Oliveira, D. (2020) · Molecules · doi:10.3390/molecules25163726 · Cited by 381
Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
Decourt, B., Lahiri, D. K., & Sabbagh, M. N. (2017) · Current Alzheimer Research · doi:10.2174/1567205013666160930110551 · Cited by 371
Ungprasert, P., Cheungpasitporn, W., Crowson, C. S., & Matteson, E. L. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.03.008 · Cited by 322
Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs
Lucas, G. N. C., Leitão, A. C. C., Alencar, R. L., Xavier, R. M. F., Daher, E. D. F., & Silva Junior, G. B. D. (2019) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2018-0107 · Cited by 307
Metadata
- Authors
- Harirforoosh, S., Asghar, W., & Jamali, F.
- Venue
- Journal of Pharmacy & Pharmaceutical Sciences
- Publisher
- Frontiers Media SA
- Published
- 2014-01-27
- Volume
- 16
- Issue
- 5
- Pages
- 821
- ISSN
- 1482-1826 (ISSN-L)
- OpenAlex
- W1575211640
- Cited by
- 960
- References
- 158
- FWCI
- 26.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.